Innate PharmaIPH 
$2.33-0.24%24h
-0.24%24h
Global rank17693
Market cap$188.15M
Change 7d0.72%
YTD Performance-19.96%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of Innate Pharma (IPH)
As of September 2024, Innate Pharma has a market cap of $188.15M. This makes Innate Pharma the world's 17693th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Innate Pharma from 2006 to 2024
-
Value:-
Market cap history of Innate Pharma from 2006 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $206.47M | -11.83% |
| 2023 | $234.18M | -20.36% |
| 2022 | $294.06M | -26.03% |
| 2021 | $397.57M | 28.48% |
| 2020 | $309.44M | -41.91% |
| 2019 | $532.71M | -19.84% |
| 2018 | $664.55M | 56.53% |
| 2017 | $424.56M | -67.49% |
| 2016 | $1.31B | 6.25% |
| 2015 | $1.23B | 74.05% |
| 2014 | $706.11M | 59.27% |
| 2013 | $443.33M | 130.70% |
| 2012 | $192.17M | 56.93% |
| 2011 | $122.45M | 17.09% |
| 2010 | $104.58M | -51.45% |
| 2009 | $215.41M | 74.64% |
| 2008 | $123.35M | -62.19% |
| 2007 | $326.24M | -41.60% |
| 2006 | $558.63M | - |
IPH Market Cap Today is $188.15M -0.24% - 7 Sept 2024
View largest stocks by market cap 
